Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
18.60
-1.49 (-7.42%)
At close: Apr 28, 2026, 4:00 PM EDT
18.50
-0.10 (-0.54%)
Pre-market: Apr 29, 2026, 7:00 AM EDT
Aktis Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -63.73 | -43.98 | -28.64 | -17.93 |
| Depreciation & Amortization | 2.33 | 1.58 | 1.12 | 0.45 |
| Loss (Gain) From Sale of Investments | -4.62 | -4.08 | -3.15 | - |
| Stock-Based Compensation | 5.13 | 2.26 | 1.48 | 0.7 |
| Other Operating Activities | - | 0.01 | -0.8 | -0.2 |
| Change in Accounts Payable | -0.04 | 0.36 | 0.66 | -0 |
| Change in Unearned Revenue | -5.5 | 58.51 | - | - |
| Change in Other Net Operating Assets | 2.31 | 0.11 | -0.67 | -1.14 |
| Operating Cash Flow | -64.13 | 14.76 | -30 | -18.13 |
| Capital Expenditures | -9.58 | -2.86 | -3.76 | -2.31 |
| Sale of Property, Plant & Equipment | - | - | 0.06 | - |
| Investment in Securities | 75.55 | -187.54 | -65.12 | - |
| Investing Cash Flow | 65.96 | -190.4 | -68.83 | -2.31 |
| Issuance of Common Stock | 0.34 | 0.18 | - | - |
| Other Financing Activities | -1.55 | -1.9 | - | -0.15 |
| Financing Cash Flow | -1.21 | 183.28 | - | 119.98 |
| Net Cash Flow | 0.63 | 7.65 | -98.83 | 99.55 |
| Free Cash Flow | -73.71 | 11.9 | -33.77 | -20.43 |
| Free Cash Flow Margin | -1134.54% | 800.27% | - | - |
| Free Cash Flow Per Share | -90.61 | 16.90 | -54.89 | -39.49 |
| Levered Free Cash Flow | -36.24 | -20.08 | -21.08 | - |
| Unlevered Free Cash Flow | -36.24 | -20.08 | -21.08 | - |
| Change in Working Capital | -3.23 | 58.98 | -0.02 | -1.14 |
Source: S&P Capital IQ. Standard template.
Financial Sources.